AI's Billion-Dollar Breakthrough
Palantir's record-breaking $1 billion revenue quarter showcases the immense growth in the artificial intelligence sector. This trend creates a significant opportunity for companies that provide the foundational technology, including AI software, semiconductor hardware, and cloud infrastructure.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Palantir's record-breaking £1 billion revenue quarter demonstrates the massive commercial potential of artificial intelligence. This milestone signals that AI has moved beyond experimental phases into widespread business adoption, creating opportunities across the entire technology ecosystem that powers these sophisticated systems.
What You Need to Know
This group focuses on the foundational technology providers that enable AI growth - from semiconductor manufacturers and cloud infrastructure giants to software innovators. These companies form the backbone of the AI revolution, providing the essential hardware, platforms, and services that make advanced AI applications possible.
Why These Stocks
These stocks were handpicked by professional analysts based on their strategic positioning within the AI value chain. Each company plays a crucial role in supporting the expanding AI ecosystem, from chip designers and cloud computing leaders to software platforms that enable AI deployment across industries.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+8.39%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 8.39% over the next year.
Stocks Rated Buy by Analysts
11 of 15 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1.5% return last month.
Why You'll Want to Watch These Stocks
Riding the AI Revenue Wave
Palantir's billion-dollar milestone proves AI is generating serious commercial returns. Companies in this space are experiencing unprecedented demand as businesses rush to integrate AI capabilities.
Infrastructure Gold Rush
As AI adoption accelerates, the demand for powerful semiconductors, cloud computing, and specialised hardware is surging. These foundational companies are positioned at the centre of this technological transformation.
Expert-Curated AI Leaders
This collection features the companies that analysts believe are best positioned to capitalise on the AI boom. From chip giants to cloud innovators, these are the names driving the industry forward.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.